Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 1, 2005, Pages 200-206

  Xu, Ying ^b   Ku, Bao Shan ^a   Yao, Hai Yan ^b   Lin, Yan Hua ^b   Ma, Xing ^b   Zhang, Yong He ^b   Li, Xue Jun ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NONE

Author keywords

Antidepressant; Brain monoamines; Curcumin; Forced swimming; Olfactory bulbectomy; Open field; Passive avoidance; Rats

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; CURCUMIN; DOPAMINE; IMIPRAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MODEL; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; HYPERACTIVITY; IMMOBILIZATION; LONG TERM CARE; MALE; MONOAMINERGIC SYSTEM; NEUROPHARMACOLOGY; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; ANTIDEPRESSIVE AGENTS; AVOIDANCE LEARNING; BIOGENIC MONOAMINES; CURCUMIN; FRONTAL LOBE; HIPPOCAMPUS; MALE; OLFACTORY BULB; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING;

CURCUMA LONGA;

EID: 26444486974     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.08.009     Document Type: Article

References (32)

1. J.R. Alberts, and M.I. Friedman Olfactory bulb removal but not ansomia increases emotionality and mouse killing Nature 238 1972 454 455
2. V. Butterweck, T. Bockers, B. Korte, W. Wittkowski, and H. Winterhoff Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus Brain Res 930 2002 21 29
3. K.D. Cairncross, B. Cox, C. Foster, and A.T. Wren Olfactory projection systems, drugs and behavior: a review Psychoneuroendocrinology 4 1979 253 272
4. J.X. Chen, and Y.T. Tang Effect on xiaoyao powder on changes of relative brain zone CRF gene expression in chronic restrained stress rats Chin J Appl Physiol 20 1 2004 71 74
5. A. Dar, and S. Khatoon Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut Pharmacol Biochem Behav 65 1 2000 1 6
6. A.S. Elhwuegi Central monoamines and their role in major depression Prog Neuro-Psychopharmacol 28 2004 435 451
7. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press San Diego
8. G. Grecksch, D. Zhou, C. Franke, U. Schroder, B. Sabel, and A. Becker Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioral correlates Br J Pharmacol 122 1997 1725 1731
9. A. Harkin, J.P. Kelly, and B.E. Leonard A review of the relevance and validity of olfactory bulbectomy as a model of depression Clin Neurosci Res 3 2003 253 262
10. K. Iwasaki, M. Fujiwara, S. Shibata, and S. Ueki Changes in brain catecholamine levels following olfactory bulbectomy and the effect of acute and chronic administration of desipramine in rats Pharmacol Biochem Behav 24 1986 1715 1719
11. S. Janscar, and B.E. Leonard The olfactory bulbectomized rat as a model of depression E. Usdin M. Goldstein A.J. Friedhoff A. Georgotas Frontiers in neuropsychiatric research 1983 Macmillan Press New York 357 372
12. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol Ther 74 3 1997 299 316
13. L.D. Kong, C.H.K. Cheng, and R.X. Tan Monoamine oxidase inhibitiors from rhizoma of Coptis chinensis Planta Med 67 2001 74 76
14. A.R. Lumia, M.H. Teicher, F. Slachli, E. Ayers, and B. Possidente Olfactory bulbectomy as a model of agitated hyposerotonergic depression Brain Res 587 1992 181 185
15. C.V. Masini, P.V. Holmes, K.G. Freeman, A.C. Maki, and G.L. Edwards Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study Physiol Behav 81 1 2004 111 119
16. E.A. Mazzio, N. Harris, and K.F. Soliman Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells Planta Med 64 7 1998 603 606
17. I.J. McLoughlin, and J.S. Hodge Zinc in depressive disorder Acta Psychiatr Scand 82 6 1990 451 453
18. R. Motterlini, R. Foresti, R. Bassi, and C.J. Green Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress Free Radic Biol Med 28 8 2000 1303 1312
19. 2A binding sites and their relationship to behavior Br J Pharmacol 117 1996 1481 1486
20. A. Nitta, Y. Furukawa, K. Hayashi, M. Hiramatsu, T. Kameyama, and T. Hasegawa Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain Neurosci Lett 144 1-2 1992 152 156
21. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, and A. Pilc Antidepressant-like effects of acute and chronic treatment with zinc in forced swimming test and olfactory bulbectomy model in rats Brain Res Bull 61 2003 159 164
22. A. Pilc, A. Klodzinska, P. Branski, G. Nowak, A. Palucha, and B. Szewczyk Multiple MPEP administrations evoke anxiolytic-and antidepressant-like effects in rats Neuropharmacology 43 2002 181 187
23. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioral despair in rat: a new model sensitive to antidepressant treatment Eur J Pharmacol 1978 379 391
24. A.M. Redmond, J.P. Kelly, and B.E. Leonard Behavioral and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression Pharmacol Biochem Behav 58 2 1997 355 359
25. A.M. Redmond, J.P. Kelly, and B.E. Leonard The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression Pharmacol Biochem Behav 62 4 1999 619 623
26. P. Schloss, and F.A. Henm New insights into the mechanisms of antidepressant therapy Pharmacol Ther 102 2004 47 60
27. G. Serra, A. Agriolas, V. Klimek, F. Fadda, and G.L. Gessa Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity Life Sci 25 1979 415 423
28. M. Thiyagarajan, and S.S. Sharma Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats Life Sci 74 2004 969 985
29. I.M. Van Rijzingen, W.H. Gispen, and B.M. Spruijt Olfactory bulbectomy temporarily impairs morris maze performance: an ACTH (4-9) analogue accelerates return of function Physiol Behav 58 1 1995 147 152
30. G. Vázquez-Palacios, H. Bonilla-Jaime, and J. Velázquez- Moctezuma Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine Pharmacol Biochem Behav 78 2004 165 169
31. A.S. Wrynn, C.P.M. Sweeney, F. Franconi, L. Lemaire, D. Pouliquen, and S. Herlidou An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression Brain Res 879 2000 193 199
32. Z.F. Yu, L.D. Kong, and Y. Chen Antidepressant activity of aqueous extracts of curcuma longa in mice J Ethnopharmacol 83 2002 161 165